Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma

Abstract Background Local treatment options for locally recurrent pancreatic adenocarcinoma (LR-PAC) are limited, with median survival time (MST) of 9–13 months (mos) following recurrence. MRI-guided stereotactic body radiation therapy (MRgSBRT) provides the ability to dose escalate while sparing no...

Description complète

Détails bibliographiques

Auteurs principaux:	Spencer J. Poiset, Sophia Shah, Louis Cappelli, Pramila Anné, Karen E. Mooney, Maria Werner-Wasik, Talya S. Laufer, James A. Posey, Daniel Lin, Atrayee Basu Mallick, Harish Lavu, Babar Bashir, Charles J. Yeo, Adam C. Mueller
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2024-05-01
Collection:	Radiation Oncology
Sujets:	MR-guided SBRT Radiation Pancreas Recurrence Toxicity
Accès en ligne:	https://doi.org/10.1186/s13014-024-02457-y
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!